UB
CYTK icon

UMB Bank’s Cytokinetics CYTK Stock Holding History

UMB Bank’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Buy
1,930
+10
+0.5% +$718 ﹤0.01% 812
2026
Q1 		$127K Buy
1,920
+136
+8% +$8.64K ﹤0.01% 866
2025
Q4 		$113K Buy
1,784
+22
+1% +$1.37K ﹤0.01% 897
2025
Q3 		$96.8K Buy
1,762
+169
+11% +$6.96K ﹤0.01% 881
2025
Q2 		$52.6K Buy
1,593
+437
+38% +$15.2K ﹤0.01% 1101
2025
Q1 		$46.5K Buy
1,156
+552
+91% +$25.4K ﹤0.01% 1083
2024
Q4 		$28.4K Buy
604
+3
+0.5% +$156 ﹤0.01% 1133
2024
Q3 		$31.7K Buy
601
+238
+66% +$13.3K ﹤0.01% 1030
2024
Q2 		$19.7K Sell
363
-6
-2% -$362 ﹤0.01% 1073
2024
Q1 		$25.9K Buy
369
+24
+7% +$1.86K ﹤0.01% 995
2023
Q4 		$28.8K Sell
345
-59
-15% -$2.14K ﹤0.01% 957
2023
Q3 		$11.9K Hold
404
– – ﹤0.01% 1237
2023
Q2 		$13.2K Hold
404
– – ﹤0.01% 1222
2023
Q1 		$14.2K Hold
404
– – ﹤0.01% 1189
2022
Q4 		$19K Hold
404
– – ﹤0.01% 1118
2022
Q3 		$20K Hold
404
– – ﹤0.01% 1106
2022
Q2 		$16K Hold
404
– – ﹤0.01% 1250
2022
Q1 		$15K Hold
404
– – ﹤0.01% 1346
2021
Q4 		$18K Buy
+404
New +$15.6K ﹤0.01% 1303

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UMB Bank's CYTK Position: Q2 2026 in Review

UMB Bank increased its Cytokinetics (CYTK) stake by 0.52% in Q2 2026, buying an estimated $718 and bringing the position to 1,930 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #812.

UMB Bank first reported a position in CYTK in Q4 2021 and has held it in 19 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • UMB Bank held 1,930 shares of Cytokinetics worth $164K as of Q2 2026.
  • UMB Bank bought 10 Cytokinetics shares in Q2 2026, an estimated $718.
  • Cytokinetics made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #812 holding.
  • UMB Bank first reported a position in Cytokinetics in Q4 2021 and has held it in 19 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.